|
G |
ABCC4 |
ATP binding cassette subfamily C member 4 (PEL blood group) |
increases transport |
EXP |
ABCC4 protein results in increased transport of Enalapril |
CTD |
PMID:17939016 |
|
NCBI chr13:95,019,835...95,301,451
Ensembl chr13:95,019,835...95,301,475
|
|
G |
ACE |
angiotensin I converting enzyme |
decreases activity multiple interactions increases expression |
EXP ISO |
Enalapril results in decreased activity of ACE protein Enalapril inhibits the reaction [Dexamethasone results in increased expression of ACE protein]; Enalapril inhibits the reaction [diisononyl phthalate promotes the reaction [Dexamethasone results in increased expression of ACE protein]]; Enalapril inhibits the reaction [Formaldehyde results in increased expression of ACE protein] ACE gene polymorphism affects the susceptibility to [Enalapril co-treated with Sodium Chloride]; ACE gene polymorphism inhibits the reaction [[Enalapril co-treated with Sodium Chloride] results in increased susceptibility to AGT protein modified form] Enalapril inhibits the reaction [Streptozocin results in increased expression of ACE mRNA]; Enalapril inhibits the reaction [Streptozocin results in increased expression of ACE protein]; Enalapril promotes the reaction [Folic Acid results in increased expression of ACE mRNA] Enalapril results in increased expression of ACE mRNA |
CTD |
PMID:15728788 PMID:15816410 PMID:20679179 PMID:20829712 PMID:23733546 PMID:28973481 PMID:30940551 PMID:36706861 More...
|
|
NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
|
|
G |
ACTA2 |
actin alpha 2, smooth muscle |
decreases expression |
ISO |
Enalapril results in decreased expression of ACTA2 protein |
CTD |
PMID:19349682 |
|
NCBI chr10:88,935,074...88,991,337
Ensembl chr10:88,935,074...88,991,339
|
|
G |
ACVRL1 |
activin A receptor like type 1 |
decreases expression |
ISO |
Enalapril results in decreased expression of ACVRL1 protein |
CTD |
PMID:12883979 |
|
NCBI chr12:51,906,944...51,923,361
Ensembl chr12:51,906,908...51,923,361
|
|
G |
ADIPOQ |
adiponectin, C1Q and collagen domain containing |
increases expression |
ISO |
Enalapril results in increased expression of ADIPOQ protein |
CTD |
PMID:25037058 |
|
NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
|
|
G |
ADRB1 |
adrenoceptor beta 1 |
increases expression |
ISO |
Enalapril results in increased expression of ADRB1 protein |
CTD |
PMID:7586371 |
|
NCBI chr10:114,043,866...114,046,904
Ensembl chr10:114,043,866...114,046,904
|
|
G |
AGT |
angiotensinogen |
decreases activity affects response to substance increases expression decreases response to substance multiple interactions decreases expression |
ISO EXP |
Enalapril results in decreased activity of AGT protein modified form AGT gene alternative form affects the susceptibility to Enalapril; AGT protein polymorphism affects the susceptibility to Enalapril Enalapril results in increased expression of AGT mRNA Enalapril results in decreased susceptibility to AGT protein modified form Enalapril affects the reaction [chymostatin results in decreased susceptibility to AGT protein modified form]; Enalapril inhibits the reaction [Cyclosporine results in increased expression of AGT protein]; Enalapril inhibits the reaction [endotoxin, Escherichia coli results in increased expression of AGT protein] Enalapril results in decreased expression of AGT protein modified form [Enalapril co-treated with Sodium Chloride] results in increased susceptibility to AGT protein modified form; ACE gene polymorphism inhibits the reaction [[Enalapril co-treated with Sodium Chloride] results in increased susceptibility to AGT protein modified form]; Enalapril inhibits the reaction [[AGT co-treated with REN] results in increased abundance of Aldosterone] Enalapril results in decreased expression of AGT mRNA |
CTD |
PMID:1330361 PMID:2474097 PMID:6319675 PMID:12003776 PMID:12911327 PMID:14659064 PMID:16685205 PMID:18300870 PMID:18679781 PMID:18796534 PMID:19114890 PMID:20829712 PMID:21602471 More...
|
|
NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
|
|
G |
AGTR1 |
angiotensin II receptor type 1 |
affects expression multiple interactions decreases expression increases expression |
ISO |
Enalapril affects the expression of AGTR1A mRNA Enalapril inhibits the reaction [Dexamethasone results in increased expression of AGTR1 protein]; Enalapril inhibits the reaction [diisononyl phthalate promotes the reaction [Dexamethasone results in increased expression of AGTR1 protein]]; Enalapril inhibits the reaction [Formaldehyde results in increased expression of AGTR1 protein] Enalapril inhibits the reaction [Cyclosporine results in decreased expression of AGTR1A mRNA] Enalapril results in decreased expression of AGTR1A mRNA Enalapril results in increased expression of AGTR1A mRNA |
CTD |
PMID:14659064 PMID:18403896 PMID:18765277 PMID:18796534 PMID:30940551 PMID:36706861 More...
|
|
NCBI chr 3:148,697,903...148,743,003
Ensembl chr 3:148,697,784...148,743,008
|
|
G |
AGTR2 |
angiotensin II receptor type 2 |
increases expression decreases expression |
ISO |
Enalapril results in increased expression of AGTR2 mRNA Enalapril results in decreased expression of AGTR2 mRNA |
CTD |
PMID:9740612 PMID:18403896 PMID:18765277 |
|
NCBI chr X:116,170,744...116,174,974
Ensembl chr X:116,170,744...116,174,974
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO |
Enalapril promotes the reaction [Isoproterenol results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:18806606 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
|
|
G |
ALPL |
alkaline phosphatase, biomineralization associated |
multiple interactions |
ISO |
Enalapril inhibits the reaction [Corticosterone results in decreased expression of ALPL mRNA]; Enalapril inhibits the reaction [Ethanol results in decreased expression of ALPL mRNA] |
CTD |
PMID:30423288 PMID:31887396 |
|
NCBI chr 1:21,508,984...21,578,410
Ensembl chr 1:21,509,397...21,578,410
|
|
G |
ANG |
angiogenin |
decreases expression |
EXP |
Enalapril results in decreased expression of ANG protein |
CTD |
PMID:3038326 |
|
NCBI chr14:20,684,177...20,694,186
Ensembl chr14:20,684,177...20,698,971
|
|
G |
ANGPT2 |
angiopoietin 2 |
multiple interactions |
ISO |
Enalapril inhibits the reaction [Streptozocin results in increased expression of ANGPT2 mRNA] |
CTD |
PMID:19958114 |
|
NCBI chr 8:6,499,632...6,563,245
Ensembl chr 8:6,499,632...6,563,409
|
|
G |
APOE |
apolipoprotein E |
multiple interactions |
EXP ISO |
[Bezafibrate co-treated with Enalapril co-treated with Dipyridamole co-treated with Atorvastatin co-treated with Valsartan] results in decreased expression of APOE protein Enalapril inhibits the reaction [APOE gene mutant form results in decreased abundance of Antioxidants]; Enalapril inhibits the reaction [APOE gene mutant form results in increased abundance of Cholesterol] |
CTD |
PMID:19603250 PMID:25037058 |
|
NCBI chr19:44,905,796...44,909,393
Ensembl chr19:44,905,791...44,909,393
|
|
G |
ATF2 |
activating transcription factor 2 |
increases expression |
ISO |
Enalapril results in increased expression of ATF2 protein |
CTD |
PMID:15531746 |
|
NCBI chr 2:175,072,259...175,168,203
Ensembl chr 2:175,072,250...175,168,382
|
|
G |
ATP1A2 |
ATPase Na+/K+ transporting subunit alpha 2 |
increases expression |
ISO |
Enalapril results in increased expression of ATP1A2 mRNA; Enalapril results in increased expression of ATP1A2 protein |
CTD |
PMID:18418421 |
|
NCBI chr 1:160,115,759...160,143,591
Ensembl chr 1:160,115,759...160,143,591
|
|
G |
ATP1A3 |
ATPase Na+/K+ transporting subunit alpha 3 |
decreases expression |
ISO |
Enalapril results in decreased expression of ATP1A3 mRNA; Enalapril results in decreased expression of ATP1A3 protein |
CTD |
PMID:18418421 |
|
NCBI chr19:41,966,582...41,994,230
Ensembl chr19:41,966,582...41,997,497
|
|
G |
AVP |
arginine vasopressin |
multiple interactions |
ISO |
Enalapril promotes the reaction [Dexamethasone results in increased activity of AVP protein] |
CTD |
PMID:3346065 |
|
NCBI chr20:3,082,556...3,084,724
Ensembl chr20:3,082,556...3,084,724
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
decreases expression |
ISO |
Enalapril results in decreased expression of BAX protein |
CTD |
PMID:21153712 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
increases expression multiple interactions |
ISO |
Enalapril results in increased expression of BCL2 protein Enalapril inhibits the reaction [Isoproterenol results in decreased expression of BCL2 protein] |
CTD |
PMID:21153712 PMID:30623541 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BDKRB1 |
bradykinin receptor B1 |
increases expression multiple interactions |
ISO |
Enalapril results in increased expression of BDKRB1 mRNA [kallidin, des-Arg(10)- results in decreased activity of BDKRB1 protein] which results in decreased susceptibility to Enalapril |
CTD |
PMID:18796534 PMID:21430409 |
|
NCBI chr14:96,256,210...96,264,763
Ensembl chr14:96,256,210...96,268,967
|
|
G |
BDKRB2 |
bradykinin receptor B2 |
increases expression |
ISO |
Enalapril results in increased expression of BDKRB2 mRNA; Enalapril results in increased expression of BDKRB2 protein |
CTD |
PMID:18190998 |
|
NCBI chr14:96,204,839...96,244,164
Ensembl chr14:96,204,679...96,244,166
|
|
G |
BGLAP |
bone gamma-carboxyglutamate protein |
multiple interactions |
ISO |
Enalapril inhibits the reaction [Corticosterone results in decreased expression of BGLAP mRNA]; Enalapril inhibits the reaction [Ethanol results in decreased expression of BGLAP mRNA] |
CTD |
PMID:30423288 PMID:31887396 |
|
NCBI chr 1:156,242,184...156,243,317
Ensembl chr 1:156,242,184...156,243,317
|
|
G |
CA2 |
carbonic anhydrase 2 |
decreases activity |
EXP |
Enalapril results in decreased activity of CA2 protein |
CTD |
PMID:28126276 |
|
NCBI chr 8:85,464,007...85,481,493
Ensembl chr 8:85,463,968...85,481,493
|
|
G |
CASP3 |
caspase 3 |
decreases activity multiple interactions |
ISO |
Enalapril results in decreased activity of CASP3 protein Enalapril inhibits the reaction [Isoproterenol results in increased expression of CASP3 protein] |
CTD |
PMID:21153712 PMID:30623541 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP9 |
caspase 9 |
decreases activity |
ISO |
Enalapril results in decreased activity of CASP9 protein |
CTD |
PMID:21153712 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CAT |
catalase |
increases activity multiple interactions |
ISO |
Enalapril results in increased activity of CAT protein Enalapril inhibits the reaction [Isoproterenol results in decreased expression of CAT protein] |
CTD |
PMID:12124199 PMID:30623541 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
multiple interactions decreases expression |
ISO EXP |
[paricalcitol co-treated with Enalapril] results in decreased expression of CCL2 protein Enalapril inhibits the reaction [sodium arsenite results in increased secretion of CCL2 protein] Enalapril results in decreased expression of CCL2 protein Enalapril results in decreased expression of CCL2 mRNA |
CTD |
PMID:10925121 PMID:17513326 PMID:19627010 PMID:20720404 PMID:25037058 PMID:28973481 More...
|
|
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CCN2 |
cellular communication network factor 2 |
decreases expression multiple interactions |
ISO |
Enalapril results in decreased expression of CCN2 mRNA; Enalapril results in decreased expression of CCN2 protein Enalapril inhibits the reaction [Streptozocin results in increased expression of CCN2 protein] |
CTD |
PMID:18812665 PMID:19349682 PMID:21416479 PMID:25037058 |
|
NCBI chr 6:131,948,176...131,951,372
Ensembl chr 6:131,948,176...131,951,372
|
|
G |
CELA2A |
chymotrypsin like elastase 2A |
decreases expression |
ISO |
Enalapril results in decreased expression of CELA2A mRNA |
CTD |
PMID:21602471 |
|
NCBI chr 1:15,456,732...15,472,091
Ensembl chr 1:15,456,728...15,472,091
|
|
G |
CLTRN |
collectrin, amino acid transport regulator |
decreases expression |
ISO |
Enalapril results in decreased expression of CLTRN mRNA; Enalapril results in decreased expression of CLTRN protein |
CTD |
PMID:12887829 |
|
NCBI chr X:15,627,318...15,675,644
Ensembl chr X:15,627,318...15,675,012
|
|
G |
CLU |
clusterin |
decreases expression |
ISO |
Enalapril results in decreased expression of CLU protein |
CTD |
PMID:12193663 |
|
NCBI chr 8:27,596,917...27,614,700
Ensembl chr 8:27,596,917...27,614,700
|
|
G |
CMA1 |
chymase 1 |
decreases expression |
ISO |
Enalapril results in decreased expression of CMA1 mRNA |
CTD |
PMID:18796534 |
|
NCBI chr14:24,505,353...24,508,265
Ensembl chr14:24,505,353...24,508,265
|
|
G |
COL1A1 |
collagen type I alpha 1 chain |
multiple interactions |
ISO |
Enalapril inhibits the reaction [Bleomycin results in increased expression of COL1A1 mRNA] |
CTD |
PMID:12003776 |
|
NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632
|
|
G |
COL3A1 |
collagen type III alpha 1 chain |
decreases expression increases expression |
ISO |
Enalapril results in decreased expression of COL3A1 mRNA Enalapril results in increased expression of COL3A1 mRNA |
CTD |
PMID:17164399 PMID:25037058 |
|
NCBI chr 2:188,974,373...189,012,746
Ensembl chr 2:188,974,373...189,012,746
|
|
G |
COL4A1 |
collagen type IV alpha 1 chain |
multiple interactions decreases expression |
ISO |
[eplerenone co-treated with Enalapril] inhibits the reaction [Aldosterone promotes the reaction [Glucose results in increased expression of COL4A1 mRNA]]; [eplerenone co-treated with Enalapril] results in decreased expression of COL4A1 mRNA; [eplerenone co-treated with Enalapril] results in decreased expression of COL4A1 protein; Enalapril inhibits the reaction [Aldosterone promotes the reaction [Glucose results in increased expression of COL4A1 mRNA]]; Enalapril inhibits the reaction [Puromycin Aminonucleoside results in increased expression of COL4A1 mRNA] Enalapril results in decreased expression of COL4A1 mRNA; Enalapril results in decreased expression of COL4A1 protein |
CTD |
PMID:9175058 PMID:18682491 |
|
NCBI chr13:110,148,963...110,307,157
Ensembl chr13:110,148,963...110,307,157
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
multiple interactions |
EXP |
Enalapril inhibits the reaction [sodium arsenite results in increased secretion of CXCL8 protein] |
CTD |
PMID:28973481 |
|
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
|
|
G |
CYBA |
cytochrome b-245 alpha chain |
multiple interactions decreases expression |
ISO |
[paricalcitol co-treated with Enalapril] results in decreased expression of CYBA protein Enalapril results in decreased expression of CYBA protein |
CTD |
PMID:20720404 PMID:25037058 |
|
NCBI chr16:88,643,289...88,651,053
Ensembl chr16:88,643,275...88,651,083
|
|
G |
CYCS |
cytochrome c, somatic |
affects localization |
ISO |
Enalapril affects the localization of CYCS protein |
CTD |
PMID:21153712 |
|
NCBI chr 7:25,118,656...25,125,260
Ensembl chr 7:25,118,656...25,125,260
|
|
G |
CYP3A4 |
cytochrome P450 family 3 subfamily A member 4 |
multiple interactions |
EXP |
Enalapril inhibits the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin] |
CTD |
PMID:19299527 |
|
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
|
|
G |
EDN1 |
endothelin 1 |
multiple interactions |
ISO |
Enalapril inhibits the reaction [Puromycin Aminonucleoside results in increased expression of EDN1 mRNA] |
CTD |
PMID:9175058 |
|
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
|
|
G |
ENG |
endoglin |
multiple interactions |
ISO |
[Enalapril co-treated with paricalcitol] results in decreased expression of ENG mRNA |
CTD |
PMID:25037058 |
|
NCBI chr 9:127,815,016...127,854,658
Ensembl chr 9:127,815,013...127,854,658
|
|
G |
EPO |
erythropoietin |
decreases expression multiple interactions |
EXP ISO |
Enalapril results in decreased expression of EPO protein Enalapril inhibits the reaction [Streptozocin results in increased expression of EPO mRNA] |
CTD |
PMID:2474097 PMID:9434678 PMID:19958114 |
|
NCBI chr 7:100,720,468...100,723,700
Ensembl chr 7:100,720,468...100,723,700
|
|
G |
EPOR |
erythropoietin receptor |
multiple interactions |
ISO |
Enalapril inhibits the reaction [Streptozocin results in increased expression of EPOR mRNA]; Enalapril inhibits the reaction [Streptozocin results in increased expression of EPOR protein] |
CTD |
PMID:19958114 |
|
NCBI chr19:11,377,207...11,384,314
Ensembl chr19:11,377,207...11,384,342
|
|
G |
F3 |
coagulation factor III, tissue factor |
decreases expression multiple interactions |
EXP |
Enalapril results in decreased expression of F3 protein Enalapril inhibits the reaction [[Shiga Toxin 1 co-treated with TNF protein] results in increased activity of F3 protein] |
CTD |
PMID:18060435 PMID:22188725 |
|
NCBI chr 1:94,529,173...94,541,759
Ensembl chr 1:94,529,173...94,541,759
|
|
G |
FASLG |
Fas ligand |
decreases expression |
ISO |
Enalapril results in decreased expression of FASLG mRNA |
CTD |
PMID:10925121 |
|
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
|
|
G |
GH1 |
growth hormone 1 |
increases response to substance |
EXP |
GH1 protein results in increased susceptibility to Enalapril |
CTD |
PMID:12883983 |
|
NCBI chr17:63,917,203...63,918,839
Ensembl chr17:63,917,200...63,918,839
|
|
G |
GJA5 |
gap junction protein alpha 5 |
multiple interactions |
ISO |
GJA5 affects the reaction [Enalapril results in increased secretion of REN protein] |
CTD |
PMID:19109587 |
|
NCBI chr 1:147,756,199...147,773,351
Ensembl chr 1:147,756,199...147,773,362
|
|
G |
GJC1 |
gap junction protein gamma 1 |
multiple interactions |
ISO |
GJC1 affects the reaction [Enalapril results in increased secretion of REN protein] |
CTD |
PMID:19109587 |
|
NCBI chr17:44,794,104...44,831,364
Ensembl chr17:44,798,448...44,830,816
|
|
G |
GSK3B |
glycogen synthase kinase 3 beta |
multiple interactions |
ISO |
Enalapril inhibits the reaction [Isoproterenol results in decreased phosphorylation of GSK3B protein] |
CTD |
PMID:18806606 |
|
NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
|
|
G |
HAS2 |
hyaluronan synthase 2 |
increases expression |
ISO |
Enalapril results in increased expression of HAS2 mRNA |
CTD |
PMID:20933085 |
|
NCBI chr 8:121,612,116...121,641,440
Ensembl chr 8:121,612,116...121,641,440
|
|
G |
HMGB1 |
high mobility group box 1 |
multiple interactions |
ISO |
Enalapril inhibits the reaction [endotoxin, Escherichia coli results in increased secretion of HMGB1 protein] Enalapril inhibits the reaction [endotoxin, Escherichia coli results in increased expression of HMGB1 protein] |
CTD |
PMID:19114890 |
|
NCBI chr13:30,456,704...30,617,597
Ensembl chr13:30,456,704...30,617,597
|
|
G |
HMOX1 |
heme oxygenase 1 |
increases expression |
ISO |
Enalapril results in increased expression of HMOX1 protein |
CTD |
PMID:21263376 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
HYAL1 |
hyaluronidase 1 |
decreases expression |
ISO |
Enalapril results in decreased expression of HYAL1 mRNA; Enalapril results in decreased expression of HYAL1 protein |
CTD |
PMID:20933085 |
|
NCBI chr 3:50,299,893...50,312,381
Ensembl chr 3:50,299,890...50,312,381
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
decreases expression multiple interactions |
ISO EXP |
Enalapril results in decreased expression of ICAM1 protein Enalapril inhibits the reaction [sodium arsenite results in increased secretion of ICAM1 protein modified form] [Enalapril co-treated with paricalcitol] results in decreased expression of ICAM1 mRNA Enalapril results in decreased expression of ICAM1 protein modified form |
CTD |
PMID:14716214 PMID:17347482 PMID:25037058 PMID:28973481 |
|
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
|
|
G |
IGF1 |
insulin like growth factor 1 |
affects expression decreases expression |
ISO |
Enalapril affects the expression of IGF1 protein Enalapril results in decreased expression of IGF1 mRNA |
CTD |
PMID:12883983 |
|
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
|
|
G |
IGFBP1 |
insulin like growth factor binding protein 1 |
increases expression |
ISO |
Enalapril results in increased expression of IGFBP1 mRNA |
CTD |
PMID:12883983 |
|
NCBI chr 7:45,888,488...45,893,660
Ensembl chr 7:45,888,360...45,893,660
|
|
G |
IL1A |
interleukin 1 alpha |
multiple interactions |
EXP |
Enalapril inhibits the reaction [IL1A protein results in increased expression of VEGFA mRNA]; Enalapril inhibits the reaction [IL1A protein results in increased expression of VEGFA protein] |
CTD |
PMID:17299153 |
|
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions decreases expression |
ISO |
Enalapril inhibits the reaction [Acrolein results in increased expression of IL1B mRNA]; Enalapril inhibits the reaction [Acrolein results in increased expression of IL1B protein]; Enalapril inhibits the reaction [Streptozocin results in increased expression of IL1B mRNA] Enalapril results in decreased expression of IL1B mRNA |
CTD |
PMID:17167242 PMID:21265103 PMID:25037058 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL6 |
interleukin 6 |
multiple interactions affects response to substance |
ISO EXP |
Enalapril inhibits the reaction [Acrolein results in increased expression of IL6 mRNA]; Enalapril inhibits the reaction [Acrolein results in increased expression of IL6 protein]; Enalapril inhibits the reaction [endotoxin, Escherichia coli results in increased expression of IL6 protein]; Enalapril inhibits the reaction [Isoproterenol results in increased expression of IL6 protein]; Enalapril inhibits the reaction [Streptozocin results in increased expression of IL6 mRNA] Enalapril inhibits the reaction [endotoxin, Escherichia coli results in increased secretion of IL6 protein] IL6 gene polymorphism affects the susceptibility to Enalapril |
CTD |
PMID:15342284 PMID:17167242 PMID:19114890 PMID:21265103 PMID:30623541 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
IRAK1 |
interleukin 1 receptor associated kinase 1 |
multiple interactions |
EXP |
[Atorvastatin co-treated with Enalapril] results in decreased expression of IRAK1 mRNA |
CTD |
PMID:20524934 |
|
NCBI chr X:154,010,507...154,019,902
Ensembl chr X:154,010,506...154,019,902
|
|
G |
ITGA2 |
integrin subunit alpha 2 |
decreases expression |
ISO |
Enalapril results in decreased expression of ITGA2 mRNA |
CTD |
PMID:25037058 |
|
NCBI chr 5:52,989,352...53,094,779
Ensembl chr 5:52,989,340...53,094,779
|
|
G |
KDR |
kinase insert domain receptor |
multiple interactions |
ISO |
Enalapril inhibits the reaction [Cyclosporine results in increased expression of KDR mRNA] |
CTD |
PMID:12110003 |
|
NCBI chr 4:55,078,481...55,125,595
Ensembl chr 4:55,078,481...55,125,595
|
|
G |
KNG1 |
kininogen 1 |
increases response to substance |
ISO |
Enalapril results in increased susceptibility to KNG1 protein modified form |
CTD |
PMID:18190998 |
|
NCBI chr 3:186,717,359...186,744,410
Ensembl chr 3:186,717,348...186,744,410
|
|
G |
LAMB1 |
laminin subunit beta 1 |
multiple interactions |
ISO |
Enalapril inhibits the reaction [Puromycin Aminonucleoside results in increased expression of LAMB1 mRNA] |
CTD |
PMID:9175058 |
|
NCBI chr 7:107,923,799...108,003,161
Ensembl chr 7:107,923,799...108,003,213
|
|
G |
LAMB2 |
laminin subunit beta 2 |
multiple interactions |
ISO |
Enalapril inhibits the reaction [Puromycin Aminonucleoside results in increased expression of LAMB2 mRNA] |
CTD |
PMID:9175058 |
|
NCBI chr 3:49,121,114...49,133,050
Ensembl chr 3:49,121,114...49,133,118
|
|
G |
LEP |
leptin |
increases response to substance |
ISO |
LEP protein results in increased susceptibility to Enalapril |
CTD |
PMID:20614101 |
|
NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
|
|
G |
MAPK9 |
mitogen-activated protein kinase 9 |
increases expression increases phosphorylation |
ISO |
Enalapril results in increased expression of MAPK9 mRNA; Enalapril results in increased expression of MAPK9 protein Enalapril results in increased phosphorylation of MAPK9 protein |
CTD |
PMID:15531746 |
|
NCBI chr 5:180,233,143...180,292,083
Ensembl chr 5:180,233,143...180,292,099
|
|
G |
MIR146A |
microRNA 146a |
multiple interactions |
EXP |
[Atorvastatin co-treated with Enalapril] results in decreased expression of MIR146A |
CTD |
PMID:20524934 |
|
NCBI chr 5:160,485,352...160,485,450
Ensembl chr 5:160,485,352...160,485,450
|
|
G |
MIR146B |
microRNA 146b |
multiple interactions |
EXP |
[Atorvastatin co-treated with Enalapril] results in decreased expression of MIR146B |
CTD |
PMID:20524934 |
|
NCBI chr10:102,436,512...102,436,584
Ensembl chr10:102,436,512...102,436,584
|
|
G |
MMP3 |
matrix metallopeptidase 3 |
decreases expression |
ISO |
Enalapril results in decreased expression of MMP3 mRNA |
CTD |
PMID:25037058 |
|
NCBI chr11:102,835,801...102,843,609
Ensembl chr11:102,835,801...102,843,609
|
|
G |
MPO |
myeloperoxidase |
multiple interactions |
ISO |
Enalapril inhibits the reaction [endotoxin, Escherichia coli results in increased activity of MPO protein] |
CTD |
PMID:19114890 |
|
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
|
|
G |
MYH6 |
myosin heavy chain 6 |
multiple interactions |
ISO |
Enalapril inhibits the reaction [Streptozocin results in decreased expression of MYH6 mRNA]; Enalapril inhibits the reaction [Streptozocin results in decreased expression of MYH6 protein] |
CTD |
PMID:15362513 |
|
NCBI chr14:23,381,987...23,408,273
Ensembl chr14:23,381,982...23,408,273
|
|
G |
MYH7 |
myosin heavy chain 7 |
decreases expression multiple interactions |
ISO |
Enalapril results in decreased expression of MYH7 mRNA Enalapril inhibits the reaction [Streptozocin results in increased expression of MYH7 mRNA]; Enalapril inhibits the reaction [Streptozocin results in increased expression of MYH7 protein] |
CTD |
PMID:15362513 PMID:21423293 |
|
NCBI chr14:23,412,740...23,435,660
Ensembl chr14:23,412,740...23,435,660
|
|
G |
NDST1 |
N-deacetylase and N-sulfotransferase 1 |
multiple interactions |
ISO |
Enalapril inhibits the reaction [Streptozocin results in decreased expression of NDST1 protein] |
CTD |
PMID:15793251 |
|
NCBI chr 5:150,497,779...150,558,211
Ensembl chr 5:150,485,818...150,558,211
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
decreases expression |
ISO |
Enalapril results in decreased expression of NFE2L2 mRNA |
CTD |
PMID:18765277 |
|
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
|
|
G |
NFKB1 |
nuclear factor kappa B subunit 1 |
decreases activity multiple interactions |
ISO |
Enalapril results in decreased activity of NFKB1 protein Enalapril inhibits the reaction [Acrolein results in increased expression of NFKB1 mRNA]; Enalapril inhibits the reaction [Acrolein results in increased expression of NFKB1 protein] |
CTD |
PMID:19225048 PMID:21265102 |
|
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
|
|
G |
NFKBIA |
NFKB inhibitor alpha |
multiple interactions |
ISO |
Enalapril inhibits the reaction [endotoxin, Escherichia coli results in increased degradation of and results in increased phosphorylation of NFKBIA protein] |
CTD |
PMID:19114890 |
|
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
|
|
G |
NOA1 |
nitric oxide associated 1 |
increases expression increases activity |
ISO |
Enalapril results in increased expression of NOA1 mRNA Enalapril results in increased activity of NOA1 protein |
CTD |
PMID:14588141 |
|
NCBI chr 4:56,963,350...56,977,606
Ensembl chr 4:56,963,350...56,977,606
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions decreases expression |
ISO |
[paricalcitol co-treated with Enalapril] results in decreased expression of NOS2 protein Enalapril results in decreased expression of NOS2 protein |
CTD |
PMID:20720404 PMID:21377515 PMID:25037058 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NOS3 |
nitric oxide synthase 3 |
multiple interactions increases expression affects expression |
ISO |
[Enalapril co-treated with eplerenone] results in decreased expression of NOS3 mRNA; Enalapril inhibits the reaction [Nitric Oxide deficiency results in decreased expression of NOS3 protein] Enalapril results in increased expression of NOS3 protein [paricalcitol co-treated with Enalapril] results in increased expression of NOS3 protein; Enalapril inhibits the reaction [Dexamethasone results in decreased expression of NOS3 protein]; Enalapril inhibits the reaction [diisononyl phthalate promotes the reaction [Dexamethasone results in decreased expression of NOS3 protein]] Enalapril affects the expression of NOS3 mRNA |
CTD |
PMID:12176110 PMID:16197366 PMID:20571278 PMID:20720404 PMID:25037058 PMID:30940551 More...
|
|
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
|
|
G |
NPPA |
natriuretic peptide A |
decreases expression |
EXP ISO |
Enalapril results in decreased expression of NPPA protein Enalapril results in decreased expression of NPPA mRNA |
CTD |
PMID:2136812 PMID:8112904 PMID:21423293 |
|
NCBI chr 1:11,845,709...11,847,783
Ensembl chr 1:11,845,709...11,848,345
|
|
G |
NPPB |
natriuretic peptide B |
multiple interactions |
ISO |
Enalapril inhibits the reaction [Isoproterenol results in increased expression of NPPB protein] |
CTD |
PMID:18806606 |
|
NCBI chr 1:11,857,464...11,858,945
Ensembl chr 1:11,857,464...11,858,945
|
|
G |
NR3C2 |
nuclear receptor subfamily 3 group C member 2 |
increases expression |
ISO |
Enalapril results in increased expression of NR3C2 mRNA |
CTD |
PMID:18796534 |
|
NCBI chr 4:148,078,764...148,445,508
Ensembl chr 4:148,078,762...148,444,698
|
|
G |
NRF1 |
nuclear respiratory factor 1 |
increases expression |
ISO |
Enalapril results in increased expression of NRF1 mRNA |
CTD |
PMID:18765277 |
|
NCBI chr 7:129,611,720...129,757,076
Ensembl chr 7:129,611,720...129,757,082
|
|
G |
PDPN |
podoplanin |
increases expression |
ISO |
Enalapril results in increased expression of PDPN protein |
CTD |
PMID:20933085 |
|
NCBI chr 1:13,583,757...13,617,957
Ensembl chr 1:13,583,465...13,617,957
|
|
G |
PPARA |
peroxisome proliferator activated receptor alpha |
multiple interactions |
ISO |
[Enalapril co-treated with Glucose] binds to PPARA protein; Enalapril inhibits the reaction [Glucose inhibits the reaction [Palmitoyl Coenzyme A analog binds to PPARA protein]] |
CTD |
PMID:18812576 |
|
NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
|
|
G |
PPARG |
peroxisome proliferator activated receptor gamma |
decreases expression multiple interactions |
ISO |
Enalapril results in decreased expression of PPARG protein Enalapril inhibits the reaction [Isoproterenol results in decreased expression of PPARG protein] |
CTD |
PMID:19225048 PMID:30623541 |
|
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
|
|
G |
PPARGC1A |
PPARG coactivator 1 alpha |
increases expression |
ISO |
Enalapril results in increased expression of PPARGC1A mRNA |
CTD |
PMID:18765277 |
|
NCBI chr 4:23,792,021...24,472,905
Ensembl chr 4:23,755,041...23,904,089
|
|
G |
PRKAA1 |
protein kinase AMP-activated catalytic subunit alpha 1 |
increases expression |
ISO |
Enalapril results in increased expression of PRKAA1 protein |
CTD |
PMID:25037058 |
|
NCBI chr 5:40,759,389...40,798,374
Ensembl chr 5:40,759,389...40,798,374
|
|
G |
PRKCA |
protein kinase C alpha |
decreases expression |
ISO |
Enalapril results in decreased expression of PRKCA protein modified form |
CTD |
PMID:21565836 |
|
NCBI chr17:66,302,613...66,810,743
Ensembl chr17:66,302,613...66,810,743
|
|
G |
PTGS1 |
prostaglandin-endoperoxide synthase 1 |
decreases expression |
ISO |
Enalapril results in decreased expression of PTGS1 mRNA |
CTD |
PMID:25037058 |
|
NCBI chr 9:122,370,533...122,395,703
Ensembl chr 9:122,370,530...122,395,703
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
decreases expression multiple interactions |
ISO |
Enalapril results in decreased expression of PTGS2 protein [paricalcitol co-treated with Enalapril] results in decreased expression of PTGS2 protein |
CTD |
PMID:20720404 PMID:21377515 PMID:25037058 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
PTH1R |
parathyroid hormone 1 receptor |
multiple interactions |
ISO |
Enalapril inhibits the reaction [Folic Acid results in decreased expression of PTH1R protein] |
CTD |
PMID:15728788 |
|
NCBI chr 3:46,877,721...46,903,799
Ensembl chr 3:46,877,721...46,903,799
|
|
G |
PTHLH |
parathyroid hormone like hormone |
multiple interactions |
ISO |
Enalapril inhibits the reaction [Folic Acid results in increased expression of PTHLH mRNA]; Enalapril inhibits the reaction [Folic Acid results in increased expression of PTHLH protein] |
CTD |
PMID:15728788 |
|
NCBI chr12:27,958,084...27,972,733
Ensembl chr12:27,958,084...27,972,733
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
Enalapril inhibits the reaction [Isoproterenol results in increased expression of RELA protein] |
CTD |
PMID:30623541 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
REN |
renin |
multiple interactions increases expression increases secretion decreases activity increases activity |
EXP ISO |
[Indomethacin co-treated with Enalapril] results in decreased expression of REN protein; Enalapril inhibits the reaction [[AGT co-treated with REN] results in increased abundance of Aldosterone] Enalapril results in increased expression of REN mRNA; Enalapril results in increased expression of REN protein Enalapril results in increased secretion of REN protein [Sodium Chloride deficiency co-treated with Enalapril] results in increased expression of REN mRNA; GJA5 affects the reaction [Enalapril results in increased secretion of REN protein]; GJC1 affects the reaction [Enalapril results in increased secretion of REN protein]; REN enhancer mutant form results in decreased susceptibility to [Sodium Chloride deficiency co-treated with Enalapril]; Sodium inhibits the reaction [Enalapril results in increased expression of REN mRNA]; Sodium inhibits the reaction [Enalapril results in increased expression of REN protein]; Sodium inhibits the reaction [Enalapril results in increased secretion of REN protein] Enalapril results in decreased activity of REN protein Enalapril results in increased activity of REN protein |
CTD |
PMID:1330361 PMID:2994932 PMID:6094050 PMID:11078175 PMID:12434137 PMID:17846348 PMID:18679781 PMID:18796534 PMID:19109587 PMID:19536436 PMID:19767874 PMID:21423293 PMID:21424707 More...
|
|
NCBI chr 1:204,154,819...204,166,337
Ensembl chr 1:204,154,819...204,190,324
|
|
G |
RUNX2 |
RUNX family transcription factor 2 |
multiple interactions |
ISO |
Enalapril inhibits the reaction [Corticosterone results in decreased expression of RUNX2 mRNA]; Enalapril inhibits the reaction [Ethanol results in decreased expression of RUNX2 mRNA] |
CTD |
PMID:30423288 PMID:31887396 |
|
NCBI chr 6:45,328,330...45,551,082
Ensembl chr 6:45,328,157...45,664,349
|
|
G |
SELE |
selectin E |
multiple interactions |
EXP |
Enalapril inhibits the reaction [sodium arsenite results in increased expression of SELE protein] |
CTD |
PMID:28973481 |
|
NCBI chr 1:169,722,640...169,734,079
Ensembl chr 1:169,722,640...169,764,705
|
|
G |
SELL |
selectin L |
multiple interactions |
ISO |
[Enalapril co-treated with paricalcitol] results in decreased expression of SELL mRNA |
CTD |
PMID:25037058 |
|
NCBI chr 1:169,690,667...169,711,620
Ensembl chr 1:169,690,665...169,711,702
|
|
G |
SELP |
selectin P |
multiple interactions decreases expression |
ISO |
Enalapril inhibits the reaction [Diclofenac results in decreased expression of SELP protein] Enalapril results in decreased expression of SELP mRNA |
CTD |
PMID:14716214 PMID:25037058 |
|
NCBI chr 1:169,588,849...169,630,124
Ensembl chr 1:169,588,849...169,630,193
|
|
G |
SERPINB2 |
serpin family B member 2 |
decreases expression |
ISO |
Enalapril results in decreased expression of SERPINB2 mRNA |
CTD |
PMID:25037058 |
|
NCBI chr18:63,887,705...63,903,888
Ensembl chr18:63,871,692...63,903,888
|
|
G |
SERPINE1 |
serpin family E member 1 |
multiple interactions decreases expression |
ISO |
[eplerenone co-treated with Enalapril] inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased expression of SERPINE1 mRNA]; [eplerenone co-treated with Enalapril] inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased expression of SERPINE1 protein]; [eplerenone co-treated with Enalapril] results in decreased expression of SERPINE1 mRNA; [eplerenone co-treated with Enalapril] results in decreased expression of SERPINE1 protein; Enalapril inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased expression of SERPINE1 mRNA]; Enalapril inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased expression of SERPINE1 protein] Enalapril results in decreased expression of SERPINE1 mRNA; Enalapril results in decreased expression of SERPINE1 protein |
CTD |
PMID:18682491 |
|
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
|
|
G |
SLC15A2 |
solute carrier family 15 member 2 |
multiple interactions |
EXP |
Enalapril inhibits the reaction [SLC15A2 protein results in increased uptake of glycylsarcosine] |
CTD |
PMID:18713951 |
|
NCBI chr 3:121,894,401...121,944,188
Ensembl chr 3:121,894,401...121,944,188
|
|
G |
SLC22A12 |
solute carrier family 22 member 12 |
multiple interactions |
EXP |
Enalapril inhibits the reaction [SLC22A12 protein results in increased uptake of Uric Acid] |
CTD |
PMID:21272127 |
|
NCBI chr11:64,591,220...64,602,344
Ensembl chr11:64,590,641...64,602,353
|
|
G |
SLC22A7 |
solute carrier family 22 member 7 |
multiple interactions |
ISO |
Enalapril inhibits the reaction [SLC22A7 protein results in increased uptake of Glutarates] |
CTD |
PMID:12065749 |
|
NCBI chr 6:43,295,714...43,305,538
Ensembl chr 6:43,295,694...43,305,538
|
|
G |
SLC22A8 |
solute carrier family 22 member 8 |
multiple interactions |
ISO |
Enalapril inhibits the reaction [SLC22A8 protein results in increased uptake of p-Aminohippuric Acid] |
CTD |
PMID:15100168 |
|
NCBI chr11:62,992,824...63,015,841
Ensembl chr11:62,989,154...63,015,841
|
|
G |
SLCO1B1 |
solute carrier organic anion transporter family member 1B1 |
affects abundance |
EXP |
SLCO1B1 gene polymorphism affects the abundance of Enalapril |
CTD |
PMID:21665049 |
|
NCBI chr12:21,131,194...21,239,796
Ensembl chr12:21,131,194...21,239,796
|
|
G |
SMAD2 |
SMAD family member 2 |
multiple interactions |
ISO |
Enalapril promotes the reaction [paricalcitol results in decreased phosphorylation of SMAD2 protein] |
CTD |
PMID:17513326 |
|
NCBI chr18:47,808,957...47,930,872
Ensembl chr18:47,808,957...47,931,146
|
|
G |
SMAD7 |
SMAD family member 7 |
increases expression |
ISO |
Enalapril results in increased expression of SMAD7 mRNA; Enalapril results in increased expression of SMAD7 protein |
CTD |
PMID:19197123 PMID:19349682 |
|
NCBI chr18:48,919,853...48,950,965
Ensembl chr18:48,919,853...48,950,965
|
|
G |
SOD1 |
superoxide dismutase 1 |
multiple interactions increases expression |
ISO |
[paricalcitol co-treated with Enalapril] results in increased expression of SOD1 protein Enalapril results in increased expression of SOD1 protein |
CTD |
PMID:20720404 PMID:25037058 |
|
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
|
|
G |
SOD2 |
superoxide dismutase 2 |
decreases activity decreases expression multiple interactions |
ISO |
Enalapril results in decreased activity of SOD2 protein Enalapril results in decreased expression of SOD2 protein [paricalcitol co-treated with Enalapril] results in decreased expression of SOD2 protein |
CTD |
PMID:18765277 PMID:20720404 PMID:25037058 |
|
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
|
|
G |
SPP1 |
secreted phosphoprotein 1 |
multiple interactions |
ISO |
[Enalapril co-treated with paricalcitol] results in decreased expression of SPP1 mRNA Enalapril inhibits the reaction [Corticosterone results in decreased expression of SPP1 mRNA]; Enalapril inhibits the reaction [Ethanol results in decreased expression of SPP1 mRNA] |
CTD |
PMID:25037058 PMID:30423288 PMID:31887396 |
|
NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
|
|
G |
SSBP1 |
single stranded DNA binding protein 1 |
increases expression |
ISO |
Enalapril results in increased expression of SSBP1 mRNA |
CTD |
PMID:18765277 |
|
NCBI chr 7:141,738,321...141,750,488
Ensembl chr 7:141,738,334...141,787,922
|
|
G |
STAT3 |
signal transducer and activator of transcription 3 |
multiple interactions |
ISO |
Enalapril inhibits the reaction [Streptozocin results in increased expression of STAT3 mRNA]; Enalapril inhibits the reaction [Streptozocin results in increased expression of STAT3 protein] |
CTD |
PMID:19958114 |
|
NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568
|
|
G |
TEK |
TEK receptor tyrosine kinase |
multiple interactions |
ISO |
Enalapril inhibits the reaction [Streptozocin results in increased expression of TEK mRNA] |
CTD |
PMID:19958114 |
|
NCBI chr 9:27,109,141...27,230,178
Ensembl chr 9:27,109,141...27,230,174
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
multiple interactions decreases expression |
ISO |
[eplerenone co-treated with Enalapril] inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased secretion of TGFB1 protein]; [eplerenone co-treated with Enalapril] inhibits the reaction [Aldosterone promotes the reaction [Glucose results in increased expression of TGFB1 mRNA]]; [eplerenone co-treated with Enalapril] results in decreased expression of TGFB1 mRNA; [eplerenone co-treated with Enalapril] results in decreased expression of TGFB1 protein; Enalapril inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased secretion of TGFB1 protein]; Enalapril inhibits the reaction [Aldosterone promotes the reaction [Glucose results in increased expression of TGFB1 mRNA]]; Enalapril inhibits the reaction [Streptozocin results in increased expression of TGFB1 mRNA]; Enalapril inhibits the reaction [Streptozocin results in increased expression of TGFB1 protein]; Enalapril promotes the reaction [paricalcitol results in decreased expression of TGFB1 mRNA]; Enalapril promotes the reaction [paricalcitol results in decreased expression of TGFB1 protein] Enalapril results in decreased expression of TGFB1 mRNA; Enalapril results in decreased expression of TGFB1 protein |
CTD |
PMID:12883979 PMID:15309289 PMID:17164399 PMID:17513326 PMID:18682491 PMID:19197123 PMID:19349682 PMID:23733546 More...
|
|
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
|
|
G |
TGFB2 |
transforming growth factor beta 2 |
decreases expression |
ISO |
Enalapril results in decreased expression of TGFB2 mRNA |
CTD |
PMID:17164399 |
|
NCBI chr 1:218,345,336...218,444,619
Ensembl chr 1:218,345,336...218,444,619
|
|
G |
TGFBI |
transforming growth factor beta induced |
decreases secretion multiple interactions |
ISO |
Enalapril results in decreased secretion of TGFBI protein [eplerenone co-treated with Enalapril] results in decreased secretion of TGFBI protein |
CTD |
PMID:18682491 |
|
NCBI chr 5:136,028,988...136,063,818
Ensembl chr 5:136,028,988...136,063,818
|
|
G |
TGFBR1 |
transforming growth factor beta receptor 1 |
decreases expression |
ISO |
Enalapril results in decreased expression of TGFBR1 mRNA; Enalapril results in decreased expression of TGFBR1 protein |
CTD |
PMID:12883979 |
|
NCBI chr 9:99,103,647...99,154,192
Ensembl chr 9:99,104,038...99,154,192
|
|
G |
THBS4 |
thrombospondin 4 |
increases expression |
ISO |
Enalapril results in increased expression of THBS4 mRNA |
CTD |
PMID:25037058 |
|
NCBI chr 5:79,991,332...80,083,287
Ensembl chr 5:79,991,311...80,083,287
|
|
G |
TLR4 |
toll like receptor 4 |
multiple interactions |
EXP |
[Atorvastatin co-treated with Enalapril] results in decreased expression of TLR4 mRNA; [Atorvastatin co-treated with Enalapril] results in decreased expression of TLR4 protein |
CTD |
PMID:20524934 |
|
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
|
|
G |
TNF |
tumor necrosis factor |
decreases expression multiple interactions |
ISO EXP |
Enalapril results in decreased expression of TNF protein Enalapril inhibits the reaction [endotoxin, Escherichia coli results in increased expression of TNF protein]; Enalapril inhibits the reaction [Isoproterenol results in increased expression of TNF protein]; Enalapril inhibits the reaction [Streptozocin results in increased expression of TNF mRNA] [paricalcitol co-treated with Enalapril] results in decreased expression of TNF protein; Enalapril inhibits the reaction [Bleomycin results in increased expression of TNF mRNA]; Enalapril inhibits the reaction [endotoxin, Escherichia coli results in increased secretion of TNF protein] Enalapril inhibits the reaction [[Shiga Toxin 1 co-treated with TNF protein] results in increased activity of F3 protein]; Enalapril inhibits the reaction [TNF protein results in increased expression of VEGFA mRNA]; Enalapril inhibits the reaction [TNF protein results in increased expression of VEGFA protein] |
CTD |
PMID:12003776 PMID:16336586 PMID:17167242 PMID:17299153 PMID:18060435 PMID:19114890 PMID:19225048 PMID:20720404 PMID:25037058 PMID:30623541 More...
|
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TOMM20 |
translocase of outer mitochondrial membrane 20 |
decreases expression |
ISO |
Enalapril results in decreased expression of TOMM20 mRNA |
CTD |
PMID:18765277 |
|
NCBI chr 1:235,109,341...235,128,837
Ensembl chr 1:235,109,341...235,128,837
|
|
G |
TRAF6 |
TNF receptor associated factor 6 |
multiple interactions |
EXP |
[Atorvastatin co-treated with Enalapril] results in decreased expression of TRAF6 mRNA |
CTD |
PMID:20524934 |
|
NCBI chr11:36,483,769...36,510,272
Ensembl chr11:36,483,769...36,510,272
|
|
G |
VCAM1 |
vascular cell adhesion molecule 1 |
affects expression decreases expression |
ISO |
Enalapril affects the expression of VCAM1 Enalapril results in decreased expression of VCAM1 mRNA; Enalapril results in decreased expression of VCAM1 protein modified form |
CTD |
PMID:17347482 PMID:19939336 |
|
NCBI chr 1:100,719,742...100,739,045
Ensembl chr 1:100,719,742...100,739,045
|
|
G |
VEGFA |
vascular endothelial growth factor A |
multiple interactions increases expression |
ISO EXP |
Enalapril inhibits the reaction [Cyclosporine results in increased expression of VEGFA protein] Enalapril inhibits the reaction [IL1A protein results in increased expression of VEGFA mRNA]; Enalapril inhibits the reaction [IL1A protein results in increased expression of VEGFA protein]; Enalapril inhibits the reaction [TNF protein results in increased expression of VEGFA mRNA]; Enalapril inhibits the reaction [TNF protein results in increased expression of VEGFA protein]; Enalapril inhibits the reaction [VEGFA protein results in increased expression of VEGFA mRNA] Enalapril results in increased expression of VEGFA protein |
CTD |
PMID:12110003 PMID:16202860 PMID:17299153 PMID:21263376 |
|
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
|
|
G |
VWF |
von Willebrand factor |
decreases expression |
ISO |
Enalapril results in decreased expression of VWF mRNA |
CTD |
PMID:25037058 |
|
NCBI chr12:5,948,877...6,124,670
Ensembl chr12:5,948,877...6,124,770
|
|